go back

Washington rates for HCPCS Q2055

Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $977,237 · 10th–90th $100,000–$1,174,8980%20%10th90th$977,237Professionalmedian $575,440 · 10th–90th $562,341–$676,0830%50%10th90th$575,440$100.0K$200.0K$500.0K$1.0M$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$616,595.00 / $1,122,018.45 / $1,348,962.88
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $588,843.66 / $776,247.12
Pacific Source
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$100,000.00 / $100,000.00 / $100,000.00
Premera BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$446,683.59 / $575,439.94 / $1,621,810.10
Premera BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$575,439.94 / $575,439.94 / $588,843.66
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $562,341.33
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$524,807.46 / $524,807.46 / $630,957.34
Wellpoint
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $724,435.96